PMC Sure Status COVID-19 Antigen Test
Diagnostic TestCOVID-19 professional use kit in out-patient departments
NCT Number: NCT05630300
This study will assess the feasibility and usability of COVID-19 professional and self-administered Antigen-Rapid Diagnostic Tests (Ag-RDTs) through health facility outpatient services and community settings in Kampala and Luwero districts in Uganda.
There are two components to this study:
1. Facility-based COVID-19 Ag-RDT professional use testing which will include people seeking care at outpatient departments and household contacts of index participants diagnosed at outpatient departments in four health facilities in Kampala and Luwero districts. 2. Community-based COVID-19 Ag-RDT self-testing which will include at-risk populations such as female sex workers (FSW) and Boda boda drivers (motorcyclists) at points of mass throughfare in Kampala and Luwero districts.
Key outcomes target the implementation's success, demand, and usability of professional and self-administered Ag-RDTs.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Kisenyi Health Center IV, Kampala, Central Region, Uganda
This study seeks to understand the feasibility and usability of COVID-19 Ag-RDT self-tests among Boda boda drivers and FSWs in community-based settings in two districts of Uganda. Ag-RDT COVID-19 professional use tests will also be assessed, among patients soliciting OPD services in health facilities, to support public-sector screening when qRT-PCR testing services are limited or unavailable. Feasibility for the purposes of this intervention refers to core factors affecting implementation success (i.e., barriers, facilitators, user preferences, and acceptability of Ag-RDT use and implementation) and demand (the measure of actual use of professional and self-administered Ag-RDTs in the population). Usability is defined as the extent to which FSWs, Boda boda drivers, and OPD patients, and household contacts of OPD patients self-report their comfort with performing critical self-testing procedures (sample collection, sample processing, and results interpretation) autonomously.
Primary Research Objective
Secondary Research Objective • Determine usability of Ag-RDT COVID-19 self-tests among FSWs, Boda boda drivers, OPD patients, and household contacts of OPD patients.
Primary outcomes: Feasibility of professional and self-administered COVID-19 Ag-RDT use.
Secondary outcomes: Usability of Ag-RDT self-administered tests.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
OPD patients (index cases) for professional use testing
Inclusion criteria
Exclusion criteria
Household contacts of OPD patients for self-testing
Inclusion criteria
Exclusion criteria
Community-based self-testing participants (FSWs and Boda boda drivers)
Inclusion criteria
Exclusion criteria
COVID-19 professional use kit in out-patient departments
COVID-19 self-test kits
Time frame: 6 months
Proportion of focus group discussion responses on the barriers, facilitators, user preferences, and acceptability to offering COVID-19 Ag-RDT professional and self-administered kits in health facilities and community settings through thematic analysis.
Time frame: 6 months
Proportion of COVID-19 OPD cases identified via professional use testing who accept self-testing kits for their contacts.
Time frame: 6 months
Proportion of FSWs, Boda boda drivers, and household contacts who use Ag-RDT COVID-19 self-tests and report their results.
Time frame: 6 months
Proportion of assisted self-testers compared to unassisted self-testers who self-report their comfort with correctly using the test and return the results, stratified by population group (OPD patients, household contacts of OPD patients, FSWs, and Boda boda drivers).
PATH
Other
Assessing the Feasibility and Usability of Implementing Professional Use and Self-administered COVID-19 Antigen RDTs in Uganda
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05096260
COVID-19, COVID-19 Pandemic
Ann Arbor, Michigan, United States
View Trial DetailsNCT05188651
COVID-19, COVID-19 Pandemic
Roma, RM, Italy
View Trial DetailsNCT07436572
COVID-19, COVID-19 Pandemic
Gaziantep, Turkey (Türkiye)
View Trial DetailsNCT06036134
Behavior, COVID-19
Phoenix, Arizona, United States
View Trial Details